テトラカイン
WordNet
- a crystalline compound used in the form of a hydrochloride as a local anesthetic
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/04/23 13:28:51」(JST)
[Wiki en表示]
Tetracaine
|
Systematic (IUPAC) name |
2-(dimethylamino)ethyl 4-(butylamino)benzoate |
Clinical data |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a682640 |
Pregnancy cat. |
? |
Legal status |
Rx Only |
Routes |
Topical, Epidural, Spinal |
Pharmacokinetic data |
Protein binding |
75.6 |
Identifiers |
CAS number |
94-24-6 Y
136-47-0 (hydrochloride) |
ATC code |
C05AD02 D04AB06 N01BA03 S01HA03 |
PubChem |
CID 5411 |
ChemSpider |
5218 Y |
UNII |
0619F35CGV Y |
KEGG |
D00551 Y |
ChEBI |
CHEBI:9468 Y |
ChEMBL |
CHEMBL698 Y |
Chemical data |
Formula |
C15H24N2O2 |
Mol. mass |
264.363 g/mol |
SMILES
- O=C(OCCN(C)C)c1ccc(NCCCC)cc1
|
InChI
-
InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3 Y
Key:GKCBAIGFKIBETG-UHFFFAOYSA-N Y
|
Y (what is this?) (verify)
|
Tetracaine (INN, also known as amethocaine; trade name Pontocaine. Ametop and Dicaine) is a potent local anesthetic of the ester group. It is mainly used topically in ophthalmology and as an antipruritic, and it has been used in spinal anesthesia.
In biomedical research, tetracaine is used to alter the function of calcium release channels (ryanodine receptors) that control the release of calcium from intracellular stores. Tetracaine is an allosteric blocker of channel function. At low concentrations, tetracaine causes an initial inhibition of spontaneous calcium release events, while at high concentrations, tetracaine blocks release completely.[1]
Chemistry
Tetracaine is synthesized from 4-butylaminobenzoic acid. The ethyl ester is formed through an acid-catalyzed esterification reaction. Base-catalyzed transesterification is achieved by boiling the ethyl ester of 4-butylaminobenzoic acid with excess 2-dimethylaminoethanol in the presence of a small amount of sodium ethoxide.[2]
Tetracaine synthesis from Winthrop Chem. Co. Patent US1889645, 1932
References
- ^ Györke, S; Lukyanenko, V et al. (1997). Dual effects of tetracaine on spontaneous sodium release in rat ventricular myocytes 500 (2). J Physiol. pp. 297–309.
- ^ Winthrop Chemical Company, Inc. U.S. Patent 1,889,645, 1932.
Further reading
- O. Eisleb, U.S. Patent 1,889,645 (1932).
Vasoprotectives (C05)
|
|
Antihemorrhoidals for topical use |
corticosteroids (Hydrocortisone, Prednisolone, Betamethasone, Fluorometholone, Fluocortolone, Dexamethasone, Fluocinolone acetonide, Fluocinonide)
local anesthetics (Lidocaine, Tetracaine, Benzocaine, Dibucaine, Procaine, Oxetacaine, Pramocaine)
other (Tribenoside)
|
|
Antivaricose therapy |
heparins or heparinoids for topical use (Organo-heparinoid, Sodium apolate, Heparin, Pentosan polysulfate)
sclerosing agents for local injection (Monoethanolamine oleate, Polidocanol, Invert sugar, Sodium tetradecyl sulfate, Phenol)
other (Calcium dobesilate)
|
|
Capillary stabilising agents |
bioflavonoids (Rutoside, Monoxerutin, Diosmin, Troxerutin, Hidrosmin) - other (Tribenoside, Etamsylate)
|
|
|
anat (a:h/u/t/a/l,v:h/u/t/a/l)/phys/devp/cell/prot
|
noco/syva/cong/lyvd/tumr, sysi/epon, injr
|
proc, drug (C2s+n/3/4/5/7/8/9)
|
|
|
|
Antipruritics (D04)
|
|
Antihistamines for topical use |
- Thonzylamine
- Mepyramine
- Thenalidine
- Tripelennamine
- Chloropyramine
- Promethazine
- Tolpropamine
- Dimetindene
- Clemastine
- Bamipine
- Isothipendyl
- Diphenhydramine
- Chlorphenoxamine
|
|
Anesthetics for topical use |
- Lidocaine
- Dibucaine
- Oxybuprocaine
- Benzocaine
- Quinisocaine
- Tetracaine
- Pramocaine
|
|
|
|
noco (i/b/d/q/u/r/p/m/k/v/f)/cong/tumr (n/e/d), sysi/epon
|
proc, drug (D2/3/4/5/8/11)
|
|
|
|
Anesthetics: Local anesthetics - primarily sodium channel blockers (N01B)
|
|
Esters |
Esters of aminobenzoic acid
|
- Amylocaine
- Benzocaine
- Butacaine
- Butamben
- Chloroprocaine
- Dimethocaine
- Meprylcaine
- Metabutethamine
- Metabutoxycaine
- Orthocaine
- Propoxycaine
- Procaine (Novocaine)
- Proxymetacaine
- Risocaine
- Tetracaine
|
|
Esters of benzoic acid
|
- 3-(p-Fluorobenzoyloxy)tropane
- Cocaine
- Cyclomethycaine
- Hexylcaine
- Piperocaine
|
|
|
Amides |
- Articaine
- Bupivacaine # /Levobupivacaine/Ropivacaine
- Butanilicaine
- Carticaine
- Dibucaine
- Etidocaine
- Lidocaine #
- Mepivacaine
- Prilocaine
- Trimecaine
|
|
Combinations |
Anesthetic/anesthetic - Lidocaine/prilocaine
Anesthetic/vasoconstrictor - Iontocaine
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
anat (h/r/t/c/b/l/s/a)/phys (r)/devp/prot/nttr/nttm/ntrp
|
noco/auto/cong/tumr, sysi/epon, injr
|
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Benzonatate inhibition of voltage-gated sodium currents.
- Evans MS1, Maglinger GB2, Fletcher AM3, Johnson SR4.
- Neuropharmacology.Neuropharmacology.2016 Feb;101:179-87. doi: 10.1016/j.neuropharm.2015.09.020. Epub 2015 Sep 16.
- Benzonatate was FDA-approved in 1958 as an antitussive. Its mechanism of action is thought to be anesthesia of vagal sensory nerve fibers that mediate cough. Vagal sensory neurons highly express the Nav1.7 subtype of voltage-gated sodium channels, and inhibition of this channel inhibits the cough re
- PMID 26386152
- Endotracheal Administration of Sufentanil and Tetracaine During Awake Fiberoptic Intubation.
- Ji M1, Tao J, Cheng M, Wang Q.
- American journal of therapeutics.Am J Ther.2016 Jan-Feb;23(1):e92-7. doi: 10.1097/MJT.0b013e31828fdb8c.
- Combined use of local anesthetics and low-dose opioids enhances the effects of local anesthetics. This study aimed to evaluate the efficacy of combined administration of sufentanil and tetracaine through the cricothyroid membrane during awake nasal intubation using fiberoptic bronchoscopy in patient
- PMID 23676347
- Biphasic decay of the Ca transient results from increased sarcoplasmic reticulum Ca leak.
- Sankaranarayanan R1, Li Y1, Greensmith DJ2, Eisner DA1, Venetucci L1,2,3.
- The Journal of physiology.J Physiol.2015 Nov 5. doi: 10.1113/JP271473. [Epub ahead of print]
- In heart failure reduction in Ca transient amplitude and contractile dysfunction can by caused by Ca leak through the sarcoplasmic reticulum (SR) Ca channel (Ryanodine Receptor, RyR) and/or decreased activity of the SR Ca ATPase (SERCA). We have characterized the effects of two forms of Ca leak (Ca-
- PMID 26537441
Japanese Journal
- Destabilization of phase-separated structures in local anesthetic-containing model biomembranes
- 神経ブロックにより診断が遅れた症候性三叉神経痛の1例
- 神経ブロックにより診断が遅れた症候性三叉神経痛の1例
★リンクテーブル★
[★]
- 英
- tetracaine
- 化
- 塩酸テトラカイン tetracaine hydrochloride
- 商
- テトカイン、(歯科)プロネスパスタアロマ・コーパロン
- 関
- 局所麻酔薬、麻酔薬
[★]
テトラカイン、塩酸テトラカイン